UBS Group AG - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,954,023
+139.3%
58,403
+120.9%
0.00%
Q2 2023$1,234,250
-79.9%
26,435
-83.5%
0.00%
-100.0%
Q1 2023$6,134,303
-45.6%
160,332
-22.1%
0.00%
-50.0%
Q4 2022$11,282,224
+8783.6%
205,880
+5437.4%
0.00%
Q3 2022$127,000
+284.8%
3,718
+6.2%
0.00%
Q2 2022$33,000
-96.5%
3,500
-94.7%
0.00%
Q1 2022$945,000
-21.4%
66,565
+17.1%
0.00%
Q4 2021$1,203,000
+24.4%
56,840
+31.4%
0.00%
Q3 2021$967,000
+279.2%
43,252
+319.9%
0.00%
Q2 2021$255,000
-69.3%
10,301
-64.0%
0.00%
Q1 2021$830,000
+422.0%
28,609
+364.9%
0.00%
Q4 2020$159,000
+205.8%
6,154
+263.9%
0.00%
Q3 2020$52,000
+44.4%
1,691
+16.5%
0.00%
Q2 2020$36,000
+71.4%
1,452
+43.6%
0.00%
Q1 2020$21,000
-70.8%
1,011
-69.0%
0.00%
Q4 2019$72,000
-48.2%
3,261
-46.6%
0.00%
Q3 2019$139,000
+561.9%
6,108
+446.3%
0.00%
Q2 2019$21,0001,1180.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders